Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1376233 | Bioorganic & Medicinal Chemistry Letters | 2008 | 4 Pages |
Abstract
A series of carbo- and heterocyclic α-hydroxy amide-derived bradykinin B1 antagonists was prepared and evaluated. A 4,4-difluorocyclohexyl α-hydroxy amide was incorporated along with a 2-methyl tetrazole in lieu of an oxadiazole to afford a suitable compound with good pharmacokinetic properties, CNS penetration, and clearance by multiple metabolic pathways.
Graphical abstractThe design and synthesis of human bradykinin B1 antagonists featuring N-methyl tetrazole and α-hydroxy amide moieties are disclosed.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Scott D. Kuduk, Ronald K. Chang, Robert M. DiPardo, Christina N. Di Marco, Kathy L. Murphy, Richard W. Ransom, Duane R. Reiss, Cuyue Tang, Thomayant Prueksaritanont, Douglas J. Pettibone, Mark G. Bock,